Physiologically-based kinetic modeling of vapours toxic to the respiratory tract

Toxicology Letters

Volumn 138, Issue 1-2, 2003, Pages 103-117

  Bogdanffy, Matthew S ^a   Sarangapani, Ramesh ^b  

^a DUPONT COMPANY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Physiological based toxicokinetics; Respiratory tract; Risk assessment; Toxicity

Indexed keywords

TOXIC GAS;

ARTICLE; CHEMICAL REACTION; DIFFUSION; HEALTH HAZARD; HUMAN; INHALATION; MODEL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RESPIRATORY SYSTEM; RISK ASSESSMENT; SOLUBILITY; TOXICOKINETICS; VAPOR;

ANIMALS; GASES; HUMANS; INHALATION EXPOSURE; MODELS, BIOLOGICAL; RESPIRATORY SYSTEM; RISK ASSESSMENT;

ANIMALIA;

EID: 0037452444     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00370-3     Document Type: Article

References (63)

1. Andersen, M.E., Introduction to toxicokinetics and its applications in chemical risk assessments. Toxicol. Lett. in press[Ed.-insert citation for this volume].
2. Andersen M.E., Sarangapani R., Frederick C.B., Kimbell J.S. Dosimetric adjustment factors for methyl methacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model. Inhal. Toxicol. 11:1999;899-926.
3. Andersen, M.E., Green, T., Frederick, C.B., and Bogdanffy, M.S. Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: Assessing the state-of-the-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate. Regul. Toxicol. Pharamcol. in press.
4. Atsushi M., Hiroshi H., Tamura H.-O., Matsui M., Katsuhiko M. Zonal distribution of sulfotransferase for phenol in olfactory sustentacular cells. EMBO J. 15:1996;2050-2055.
5. Bird R.B., Stewart W.E., Lightfoot E.N. Transport Phenomena. 1960;Wiley, New York.
6. Bogdanffy M.S., Keller D.A. Metabolism of xenobiotics by the respiratory tract. Gardner D.E., Crapo J.D., McClellan R.O. Toxicology of the Lung. 1999;85-123 Taylor and Francis, Philadelphia, PA.
7. Bogdanffy M.S., Mathison B.H., Kuykendall J.R., Harman A.E. Critical factors in assessing risk from exposure to nasal toxicants. Mutat. Res. 1997;125-141.
8. Bogdanffy M.S., Morgan P.H., Starr T.B., Morgan K.T. Binding of formaldehyde to human and rat nasal mucus and bovine serum albumin. Toxicol. Lett. 38:1987;145-154.
9. Bogdanffy M.S., Sarangapani R., Plowchalk D.R., Jarabek A., Andersen M.E. A biologically-based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity. Toxicol. Sci. 51:1999;19-35.
10. Bogdanffy M.S., Sarangapani R., Kimbell J.S., Frame R.S., Plowchalk D.R. Analysis of vinyl acetate metabolism in rat and human nasal tissues by an in vitro gas uptake technique. Toxicol. Sci. 46:1998;235-246.
11. Bond J.A., Harkema J.R., Russell V.I. Regional distribution of xenobiotic metabolizing enzymes in respiratory airways of dogs. Drug Metab. Dispos. 16:1988;116-124.
12. Bush M.L., Frederick C.B., Kimbell J.S., Ultman J.S. A CFD-PBPK hybrid model for simulating gas and vapor uptake in the rat nose. Toxicol. Appl. Pharmacol. 150:1998;133-145.
13. Cappiello M., Giuliani L., Pacifici G.M. Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5′-diphosphoglucuronic acid in human tissues. Euro. J. Clin. Pharmacol. 41:1991;345-350.
14. Chang H.K., Paiva M. Respiratory Physiology: An Analytical Approach. 1989;Dekker, New York.
15. Cho H.Y., Hotchkiss J.A., Harkema J.R. Inflammatory and epithelial responses during the development of ozone-induced mucous cell metaplasia in the nasal epithelium of rats. Toxicol. Sci. 51:(1):1999;135-145.
16. Clewell H.J., Andersen M.E., Barton H.A. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Enivron. Health Perspect. 110:2002;85-93.
17. Clouter A., Houghton C.E., Bowskill C.A., Hibbs L.R., Brown R.C., Hoskins J.A. Effect of inhaled fibers on the glutathione concentration and γ-glutamyl transpeptidase activity in lung type II epithelial cells, macrophages, and bronchoalveolar lavage fluid. Inhalation Toxicol. 9:1997;351-367.
18. Cussler E.L. Diffusion: Mass Transfer in Fluid Systems. 1999;Cambridge University Press, Cambridge, UK.
19. Ding X., Sheng J., Hua Z., Guo J., Caggana M. Identification of a new human CYP2A gene fragment with close linkage to CYP2GP1. Drug Metab. Dispos. 29:2001;4-7.
20. Dorman D.C., Miller K.L., D'Antonio A., James R.A., Morgan K.T. Chloroform-induced olfactory mucosal degeneration and osseous ethmoid hyperplasia are not associated with olfactory deficits in Fischer 344 rats. Toxicology. 122:1997;39-50.
21. Fokert P.G. Conjugation of glutathione with the reactive metabolites of 1,1-dichloroethylene in murine lung and liver. Microscopy Res. Tech. 36:1997;234-242.
22. Fourman, G.L., Timchalk, C., Weitz, K.K., Schwartz, R.E., Thrall, K.D. 2002. An innovative, real-time method to evaluate the breath-to-breath nasopharyngeal concentration in the human volunteer. Toxicol. Sci., Suppl. 66 (1-S), abstract LB147.
23. Frederick C.B., Gentry P.R., Bush M.L., Lomax L.G., Black K.A., Finch L., Kimbell J.S., Morgan K.T., Subramaniam R.P., Morris J.B., Ultman J.S. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapours in the rat and human nasal cavities following inhalation exposure. Inhal. Toxicol. 13:2001;359-376.
24. Genter M.B., Llorens J., O'Callaghan J.P., Peele D.B., Morgan K.T., Crofton K.M. Olfactory toxicity of β,β′-iminodipropionitrile in the rat. J. Pharmacol. Exp. Ther. 263:1992;1432-1439.
25. Gross E.A., Morgan K.T. Architecture of nasal passages and larynx. Parent R.A. Comparative Biology of the Normal Lung. 1991;7-25 CRC Press, Boca Raton, FL.
26. Hanna L.M., Lou S.-R., Su S., Jarabek A.M. Mass transport analysis: inhalation RfC methods framework for interspecies dosimetric adjustment. Inhalation Toxicol. 13:2001;415-463.
27. Hatch G.E., Harkema J.R., Plopper C.G., Harris L. Ozone dosimetry studies in the nose and eye using oxygen-18. Inhalation Toxicol. 6:(Suppl):1995;125-134.
28. Hurtt M.E., Thomas D.A., Working P.K., Monticello T.M., Morgan K.T. Degeneration and regeneration of the olfactory epithelium following inhalation exposure to methyl bromide: pathology, cell kinetics, and olfactory function. Toxicol. Appl. Pharmacol. 94:1988;311-328.
29. Jones K.G., Holland J.F., Foureman G.L., Bend J.R., Fouts J.R. Induction of xenobiotic metabolism in Clara cells and alveolar type II cells isolated from rat lungs. J. Pharmacol. Exp. Ther. 225:1983;316-319.
30. Kety S. The theory and applicatins of the exchange of inert gas at the lungs and tissues. Pharmacol. Rev. 3:1951;1-42.
31. Kimbell J.S., Subramaniam R.P. Use of computational fluid dynamics models for dosimetry of inhaled gases in the nasal passages. Inhal. Toxicol. 13:2001;325-334.
32. Kimbell J.S., Godo M.N., Gross E.A., Joyner D.R., Richardson R.B., Morgan K.T. Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol. Appl. Pharmacol. 145:1997;388-398.
33. Kimbell J.S., Gross E.A., Richardson R.B., Conolly R.B., Morgan K.T. Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages. Mutat. Res. 380:1997;143-154.
34. Knight J.A., Resuke W.N., Gillies C.G., Hopfer S.M., Sunderman F.W. Pulmonary histopathology of rats following parenteral injections of nickel chloride. Toxicol. Pathol. 16:1988;350-359.
35. Kudo S. Differentiation of Clara cells and pneumocytes of the rat by means of enzyme-and immunohistochemistry. Anat. Rec. 238:1994;49-56.
36. Landahl H.D., Herrmann R.G. Retention of vapours and gases in the human nose and lung. Arch. Ind. Hyg. 1:1950;36-45.
37. Lindh C.H., Jonsson B.A., Johannesson G., Zhang X.D., Welinder J., Brittebo E.B. Binding of the potent allergen hexhydrophthalic anhydride in the mucosa of the upper respiratory and alimentary tract following single inhalation exposure in guinea pigs and rats. Toxicology. 134:1999;153-168.
38. Longo V., Mazzaccaro A., Ventura P., Gervasi P.G. Drug-metabolizing eznymes in respiratory nasal mucosa and liver of cynomolgus monkeys. Xenobiotica. 22:1992;427-431.
39. Mainwaring G., Foster J.R., Lund V., Green T. Methyl methacrylate toxicity in rat nasal epithelium. Studies of the mechanism of action and comparisons between species. Toxicology. 158:2001;109-118.
40. Medinsky M.A., Bond J.A., Schlosser P.M., Morris J.B. Mechanisms and models for respiratory-tract uptake of volatile organic chemicals. Gardner D.E., Crapo J.D., McClellan R.O. Toxicology of the Lung. third ed. 1999;483-512 Taylor and Francis, Philadelphia, PA.
41. Monticello T.M., Miller F.J., Morgan K.T. Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. Toxicol. Appl. Pharmacol. 111:1991;409-421.
42. Morgan K.T., Monticello T.M. Airflow, gas deposition, and lesion distribution in the nasal cavity. Environ. Health Perspect. 85:1990;209-218.
43. Morris J.B. First-pass metabolism of inspired ethyl acetate in the upper respiratory tracts of the F344 rat and Syrian hamster. Toxicol. Appl. Pharmacol. 102:1990;331-345.
44. Morris J.B. In vivo measures of uptake. Miller F.J. Nasal Toxicity and Dosimetry of Inhaled Xenobiotics: Implications for Human Health. 1995;99-111 Taylor and Francis, Philadelphia, PA.
45. Morris J.B., Blanchard K.T. Upper respiratory tract deposition of inspired acetaldehyde. Toxicol. Appl. Pharmacol. 114:1992;140-146.
46. Morris J.B., Hassett D.N., Blanchard K.T. A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapours. Toxicol. Appl. Pharmacol. 123:1993;120-129.
47. Nash T., Pattle R.E. Absorption of phosgene by aqueous solutions and its relation to toxicity. Ann. Occup. Hyg. 14:1971;227-233.
48. Overton J. Dosimetry modeling of highly soluble reactive gases in the respiratory tract. Inhal. Toxicol. 13:2001;347-357.
49. Parent R.A. Comparative Biology of the Normal Lung. Treatise on Pulmonary Toxicology. 1:1992;CRC Press, Inc, FL.
50. Plopper C.G., Macklin J., Nishio S.J., Hyde D.M., Buckpitt A.R. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity III. Morphometric comparison of changes in epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters and rts after parenteral administration of naphthalene. Lab. Invest. 67:1992;553-565.
51. Potter D.W., Finch L., Udinsky J.R. Glutathione content and turnover in rat nasal epithelia. Toxicol. Appl. Pharmacol. 135:1995;185-191.
52. Sabo J.P., Kimmel E.C., Diamond L. Effects of the Clara cell toxin, 4-ipomeanol, on pulmonary function in rats. J. Appl. Physiol.: Res. Environ. Exercise Physiol. 54:1983;337-344.
53. Sarangapani, R., Teeguarden, J.G., Cruzan, G., Clewell, H.J., Andersen, M.E. 2002. Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory tract dosimetry in rodents and humans. Inhal. Toxicol. in press.
54. Schlosser P.M. Relative roles of convection and chemical reaction for the disposition of formaldehyde and ozone in nasal mucus. Inhal. Toxicol. 11:1999;967-980.
55. Schreider J.P. Comparative anatomy and function of the nasal passages. Barrow C.S. Toxicology of the Nasal Passages. 1986;1-25 Hemisphere Publishing Corp, New York.
56. Snipes M.B., Spoo J.W., Brookins L.K., Jones S.E., Mauderly J.L., Orwat T.B., Stiver J.H., Dahl A.R. A method for measuring nasal and lung uptake of inhaled vapor. Fundam. Appl. Toxicol. 16:1991;81-91.
57. Stott W.T., Ramsey J.C., McKenna M.J. Absorption of chemical vapours by the upper respiratory tract of rats. Barrow C.S. Toxicology of the Nasal Passages. 1986;191-210 Hemishpere Publishing Corp, Washington.
58. Subramaniam R., Richardson R.B., Morgan K.T., Kepler G., Kimbell J.S., Guilmette R.A. Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhal. Toxicol. 10:1998;91-120.
59. Talamo B.R., Feng W.-H., Stockmayer M. Human olfactory epithelium: normal patterns and types of lesions found in the general population. Inhal. Toxicol. 6:(Suppl):1995;249-275.
60. Thornton-Manning J.R., Dahl A.R. Metabolic capacity of nasal tissue. Interspecies comparisons of xenobiotic-metabolizing enzymes. Mutat. Res. 380:1997;43-59.
61. United States Environmental Protection Agency (US EPA) 1994. Methods for derivation of inhalation reference concentration and application of inhalation dosimetry. EPA/600/8-90/066F.
62. Uriah L.C., Maronpot R.R. Normal histology of the nasal cavity and application of special techniques. Environ. Health Perspect. 85:1990;187-208.
63. van Birgelen A.P.J.M., Chou B.J., Renne R.A., Grumbein S.L., Roycroft J.H., Hailey J.R., Bucher J.R. Effects of glutaraldehyde in a 2-year inhalation study in rats and mice. Toxicol. Sci. 55:(1):2000;195-205.